MPA
AMGN icon

Marvin & Palmer Associates’s Amgen AMGN Stock Holding History

Marvin & Palmer Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,305
Closed -$4.55M – 31
2020
Q2 		$4.55M Buy
+19,305
New +$4.4M 2.75% 22
2016
Q2 		– Sell
-6,100
Closed -$915K – 39
2016
Q1 		$915K Buy
6,100
+200
+3% +$29.7K 1.07% 34
2015
Q4 		$958K Sell
5,900
-2,850
-33% -$448K 0.98% 39
2015
Q3 		$1.21M Sell
8,750
-1,150
-12% -$181K 1.45% 35
2015
Q2 		$1.52M Sell
9,900
-100
-1% -$16K 1.44% 33
2015
Q1 		$1.6M Buy
10,000
+833
+9% +$131K 1.39% 38
2014
Q4 		$1.46M Buy
+9,167
New +$1.43M 1.48% 31
2013
Q3 		– Sell
-19,000
Closed -$1.88M – 73
2013
Q2 		$1.88M Buy
+19,000
New +$1.97M 1.02% 43

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Marvin & Palmer Associates's AMGN Position: Q3 2020 in Review

Marvin & Palmer Associates sold out of Amgen (AMGN) in Q3 2020, closing a stake of 19,305 shares — an estimated $4.55M sold.

Marvin & Palmer Associates first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $4.55M in Q2 2020. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Marvin & Palmer Associates reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Marvin & Palmer Associates sold 19,305 Amgen shares in Q3 2020, an estimated $4.55M.
  • Marvin & Palmer Associates first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Marvin & Palmer Associates's Amgen position peaked at $4.55M in Q2 2020.
  • 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Marvin & Palmer Associates's 13F filing for Q3 2020, filed 12 Nov 2020.